Johnson & Johnson pauses COVID-19 vaccine trial as participant becomes ill

Johnson & Johnson said it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick. “We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,” the company said in a statement. The pause means the enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.

Source: Barron’s